RAVI HARI PHULWARE
@aiimsrishikesh.edu.in
Assistant Professor, Pathology & Laboratory Medicine/ravipaarti@gmail.com
Ravi Hari Phulware/All India Institute of Medical Sciences Rishikesh
Consultant Histopathologist
Cytopathologist
Onco-pathologists
More than 10 years of experience in the field of Pathology
More than 50 PubMed publication in various International and National Journals
EDUCATION
MBBS
MD Pathology
PGDM Executive (NIHFW) Hospital Management
RESEARCH, TEACHING, or OTHER INTERESTS
Pathology and Forensic Medicine, Histology, Oncology, Nephrology
FUTURE PROJECTS
Molecular landscape of Hereditary cancer gene panel in urinary bladder cancer in young adults of Sub Himalayan region of Uttarakhand and Western Uttar Pradesh
There is limited information on an exome scale about the germline molecular alteration leading to urinary bladder cancer in young patients in India. Patients from Uttarakhand and Western Uttar Pradesh are usually from low socioeconomic strata and come with advanced stages of tumor. Hence there is a felt need of doing exome profiling study to pick up the gene mutations in this region. This will add to the understanding of the pathogenesis of disease and will help in making a gene panel for early screening and detection.
Applications Invited
Scopus Publications
Scopus Publications
Shalini Rajaram, Ayush Heda, Latika Chawla, and Ravi Hari Phulware
Springer Science and Business Media LLC
Shalini Rajaram, Lakhwinder Singh, Ayush Heda, Latika Chawla, Ravi Hari Phulware, Ashok Singh, and Simardeep Kaur
Elsevier BV
Nishi Jha, Ravi Hari Phulware, Arvind Kumar, Ashok Singh, Prashant Durgapal, Nilotpal Chowdhury, Ankur Mittal, and Sanjeev Kishore
Springer Science and Business Media LLC
Palak Nandolia, Khanak Kumar Nandolia, Ravi Hari Phulware, and Sonal Saran
BMJ
Sonali Mishra, Ravi Hari Phulware, Akash Dhiman, Bibek Keshari, Ashok Singh, and Arvind Kumar
Springer Science and Business Media LLC
Ravi Hari Phulware, Gayathri K S, Gaurav Rajendra Shirsath, and Amit Gupta
Editora Cubo
undergone a radical prostatectomy two years ago with Gleason grade group 5. Scrotal ultrasound showed a hypoechoic mass involving the right testicle with increased vascularity, suggesting a neoplastic lesion. Hence, the patient was planned for a bilateral orchidectomy. The patient underwent bilateral inguinal orchiectomy without any complications. Macroscopic examination of the right resected testis revealed a solid yellowish-white tumor of 0.5 × 0.5 cm. Histopathological analysis showed that the right testis was infiltrated by metastatic adenocarcinoma. Immunohistochemical examination revealed that tumor cells were diffusely positive for PSA and Alpha ( α )-methylacyl-CoA racemase (AMACR). The patient was diagnosed with right testicular metastasis of Prostatic Carcinoma. The patient had an uneventful postoperative recovery. The patient was scheduled for regular follow-up appointments to monitor disease progression. Serial PSA levels and imaging studies were planned to look for disease status.
Divya Kumari, B. Darshan, Shrikant Shukla, Erna Ahsan, Ashok Singh, and Ravi H. Phulware
Medknow
Ravi Hari Phulware, Shalini Jain, Akash Dhiman, Arvind Ahuja, and Arvind Kumar
Editora Cubo
Deepali Saxena, Ravi Hari Phulware, Prashant Durgapal, Arvind Kumar, and Amit Kumar Tyagi
Springer Science and Business Media LLC
Samikshya Thapa, Gajendra Kumar Yadav, Ratna Mondal, and Ravi Hari Phulware
Editora Cubo
ABSTRACT Esophageal melanocytosis is a rare entity defined by the proliferation of a melanocytic basal layer of the esophageal squamous lining and deposition of melanin in the esophageal mucosa. Esophageal melanocytosis is considered a benign entity of unknown etiology; however, it has been reported as a melanoma precursor. We report a case of esophageal melanocytosis in a diabetic and hypertensive 67-year-old male with recurrent dizziness and syncope for the past 6 months. Given his complaint of dyspepsia, he underwent an upper gastrointestinal endoscopy, in which an esophageal biopsy revealed the diagnosis of esophageal melanocytosis. The definitive diagnosis of esophageal melanocytosis can only be made by histological analysis. The histologic differential diagnoses include melanocytic nevi and malignant melanoma. Therefore, they need to be ruled out.
Sonal Saran and Ravi Hari Phulware
Springer Science and Business Media LLC
Sonali Mishra, Ramit K. Shah, Kavya Udyavar, Arvind Kumar, and Ravi H. Phulware
Medknow
Palak Nandolia, Khanak Nandolia, Ravi Hari Phulware, and Sonal Saran
Springer Science and Business Media LLC
Palak Nandolia, Khanak Nandolia, Ravi Hari Phulware, and Sonal Saran
Springer Science and Business Media LLC
Akansha Bhatia, Ravi H. Phulware, and Arvind Ahuja
Medknow
Sonali Mishra, Ashok Singh, Arvind Kumar, and Ravi Hari Phulware
Editora Cubo
RaviH Phulware, Samikshya Thapa, Arvind Kumar, and Sanjeev Kishore
Medknow
Pooja Semwal, Rishi Bolia, Nikhil Rajvanshi, Ravi Hari Phulware, and Nowneet Kumar Bhat
Springer Science and Business Media LLC
Arvind Kumar, Tushar Kalonia, Akanksha Gupta, and Ravi Hari Phulware
Editora Cubo
moderate cytoplasm. A few cells showed cytoplasmic clearing. The peritumoral desmoplastic reaction was also identified with intratumorally brisk mitotic figures. Focal areas of necrosis with acute and chronic inflammatory infiltrate were also identified. Immunohistochemistry revealed tumor cells to be diffusely positive for cytokeratin 7 (CK7) and CK19 (Figure 1C and 1D) and negative for CK20, thyroid transcription factor (TTF-1), Gross Cystic Disease Fluid Protein-15 (GCDFP-15), mammaglobin, Hepatocyte Paraffin 1 (Hep Par1), Paired box gene 8 (PAX-8) and Wilms tumor gene 1 (WT1). An abdominal computed tomography scan on imaging workup revealed a gallbladder mass with multiple liver lesions and brain metastasis. Based on immunohistochemistry and imaging findings, the diagnosis was metastatic gall bladder carcinoma to the scalp.
Ravi Hari Phulware, Amrita Talwar, and Arvind Ahuja
Editora Cubo
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 1 All India Institute of Medical Sciences, Department of Pathology and Laboratory Medicine, Rishikesh, Uttarakhand, India 2 ABVIMS, PGIMER & Dr Ram Manohar Lohia Hospital, Department of Pathology, New Delhi, India Cavernous hemangioma of the parotid gland
Pallavi Verma, Shalini Rajaram, Raj Kumar Kottayasamy seenivasagam, and Ravi Hari Phulware
BMJ
Growing teratoma syndrome (GTS) is a tumour growth, which contains mature teratomatous elements during or after chemotherapy for malignant germ cell tumours. Surgery is the only potential treatment option for GTS because these growing teratomas are resistant to chemotherapy and radiation therapy. Extensive surgeries may be needed in GTS with multivisceral resections to achieve no residual disease status. This report presents a case of GTS treated with multiple surgical resections in a woman with malignant immature teratoma ovary in her early thirties; she is disease free after 1 year of treatment.
Durre Aden, Ravi Hari Phulware, Manju Kaushal, and Arvind Ahuja
Wiley
Myxoid liposarcoma variant of liposarcoma which constitutes around 15% to 20% to one-fourth of all liposarcoma (LPS). 1 They are most commonly seen in the thigh in the deeper soft tissue with rare cases found in the foot (1.3% – 2.7%) or leg (6.7% – 13.5%). 2 The male to female ratio is 1.1:1 with age ranging between 17 and 76 years and a mean age of 52 years. The size ranges between 2 and 32 cm (mean: 9.7 cm). 1 As per the recent WHO 2020 there are five types of liposarcomas namely well-differentiated, myxoid, round cells, pleomorphic and the newly introduced myxoid pleomorphic liposarcoma. 1 – 3 They present as a rapidly enlarging, painless mass; 30% of patients may have dull aching pain or tenderness with few giving a history of trauma in the affected area. 1 There is no specific diagnostic finding on MRI and it may mimic a ganglion cyst at times. Soft-tissue sarcomas are generally restricted to one
Anu Singh, Ravi Hari Phulware, Arvind Ahuja, Ankur Gupta, and Manju Kaushal
Springer Science and Business Media LLC